Clinical importance of PCA3 lncRNA aberrant expression in chronic myeloid leukemia patients: a comparative method

He Ling; Zhang Jie; Peng Yang; Wu Hongwei; Sun Zhiqiang

doi:10.1515/tjb-2021-0114

Türk Biyokimya Dergisi (Aug 2023)

Clinical importance of PCA3 lncRNA aberrant expression in chronic myeloid leukemia patients: a comparative method

He Ling,
Zhang Jie,
Peng Yang,
Wu Hongwei,
Sun Zhiqiang

Affiliations

He Ling: The First Affiliated Hospital of Chengdu Medical College, Chengdu, China
Zhang Jie: The First Affiliated Hospital of Chengdu Medical College, Chengdu, China
Peng Yang: The First Affiliated Hospital of Chengdu Medical College, Chengdu, China
Wu Hongwei: The First Affiliated Hospital of Chengdu Medical College, Chengdu, China
Sun Zhiqiang: Department of Hematology, Shenzhen Hospital of Southern Medical University, Shenzhen, Guangdong, China

DOI: https://doi.org/10.1515/tjb-2021-0114
Journal volume & issue: Vol. 48, no. 4
pp. 345 – 350

Abstract

Read online

Long noncoding RNAs (lncRNAs) plays important role in disease spread and its invasion. Overexpression of prostate cancer antigen 3 gene (PCA3gene) is reported in prostate cancer. To analyze the PCA3 lncRNA expression in chronic myeloid leukemia (CML) patients.

Published in Türk Biyokimya Dergisi

ISSN: 1303-829X (Online)
Publisher: De Gruyter
Country of publisher: Germany
LCC subjects: Science: Chemistry: Organic chemistry: Biochemistry
Website: https://www.degruyter.com/journal/key/tjb/html

About the journal

Abstract

Keywords